Corcept Therapeutics, Inc.
(NASDAQ : CORT)

( )
CORT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.48%166.090.7%$1108.87m
PFEPfizer Inc. -0.72%49.750.9%$939.86m
ABBVAbbVie, Inc. -0.22%142.291.9%$831.12m
MRKMerck & Co., Inc. -0.47%90.590.7%$806.25m
LLYEli Lilly & Co. 1.90%313.931.1%$798.53m
BMYBristol-Myers Squibb Co. -1.36%74.541.0%$648.45m
SIGASIGA Technologies, Inc. 5.66%26.150.0%$514.56m
AZNAstraZeneca Plc 0.26%66.811.0%$373.58m
GBTGlobal Blood Therapeutics, Inc. 0.43%67.045.6%$334.64m
ALNYAlnylam Pharmaceuticals, Inc. -1.21%231.018.2%$285.62m
GSKGSK Plc -3.08%34.920.3%$275.20m
HZNPHorizon Therapeutics Plc -3.81%64.905.4%$222.52m
KRTXKaruna Therapeutics, Inc. -1.34%273.710.0%$217.12m
CCXIChemoCentryx, Inc. 0.18%50.812.9%$205.42m
RGENRepligen Corp. 1.74%255.736.7%$190.66m

Company Profile

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.